Trial Profile
Comparison of psychotherapy and pharmacotherapy on improvement of mental health of depressed women with recurrent spontaneous miscarriage
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Sep 2020
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Anxiety disorders; Depressive disorders
- Focus Therapeutic Use
- 22 Jun 2013 Status changed from not yet recruiting to recruiting as reported by Iranian Registry of Clinical Trials.
- 11 May 2013 Recruitment is expected to complete on the 22nd of June 2015
- 11 May 2013 New trial record